Statins might benefit COVID-19 patients due to their anti-inflammatory and antioxidant effects: (1) bind to the SARS-CoV-2 main protease and prevent invasion of the host cells [6]; (2) activate autophagy and regulate SARS-CoV-2 virus degradation or replication, which may reduce viral load; (3) modulate the immune response by blocking the NF-κB pathway and NLRP3 inflammasomes, so theoretically decrease the cytokine storm in COVID-19 [6]; and (4) improve the endothelial function, which participates in the pathogenesis of the COVID-19 [7]. This evidence concerns the gene NLRP3 and COVID-19.